These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 15985047)
1. Motivations and perceived influences on rural and urban general practitioners when prescribing conventional non-steroidal anti-inflammatory drugs or COX-2 inhibitors. Behan K; Cutts C; Tett SE J Clin Pharm Ther; 2005 Aug; 30(4):337-43. PubMed ID: 15985047 [TBL] [Abstract][Full Text] [Related]
2. Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease. Joshua FF; Oakley SP; Major GA Intern Med J; 2004 Apr; 34(4):153-61. PubMed ID: 15086694 [TBL] [Abstract][Full Text] [Related]
3. A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitors. Schneeweiss S; Glynn RJ; Avorn J; Solomon DH J Clin Epidemiol; 2005 Jan; 58(1):98-102. PubMed ID: 15649677 [TBL] [Abstract][Full Text] [Related]
4. Emergency contraception. General practitioner knowledge, attitudes and practices in New South Wales. Weisberg E; Fraser IS; Carrick SE; Wilde FM Med J Aust; 1995 Feb; 162(3):136-8. PubMed ID: 7854225 [TBL] [Abstract][Full Text] [Related]
5. Treating osteoarthritis in practice--the TOP Study. Knott L Curr Med Res Opin; 2000; 16(2):147-52. PubMed ID: 10893659 [TBL] [Abstract][Full Text] [Related]
6. Long-term NSAID use in primary care: changes over a decade and NICE risk factors for gastrointestinal adverse events. Thompson PW; Tee L; McBride J; Quincey D; Strat Liddiard G Rheumatology (Oxford); 2005 Oct; 44(10):1308-10. PubMed ID: 15972345 [TBL] [Abstract][Full Text] [Related]
7. Influences on doctors' prescribing: is geographical remoteness a factor? Cutts C; Tett SE Aust J Rural Health; 2003 Jun; 11(3):124-30. PubMed ID: 12950395 [TBL] [Abstract][Full Text] [Related]
8. National trends in cyclooxygenase-2 inhibitor use since market release: nonselective diffusion of a selectively cost-effective innovation. Dai C; Stafford RS; Alexander GC Arch Intern Med; 2005 Jan; 165(2):171-7. PubMed ID: 15668363 [TBL] [Abstract][Full Text] [Related]
9. Non-steroidal anti-inflammatory drug prescribing patterns in general practice: comparison of a general practitioner-based survey and a pharmacy-based survey in France. Clinard F; Sgro C; Bardou M; Dumas M; Hillon P; Bonithon-Kopp C Pharmacoepidemiol Drug Saf; 2001; 10(4):329-38. PubMed ID: 11760495 [TBL] [Abstract][Full Text] [Related]
10. Nonsteroidal anti-inflammatory drugs and potential risks in a convenience sample of general practitioners. Cutts C; LaCaze A Aust Fam Physician; 2002 Jun; 31(6):590-2. PubMed ID: 12154611 [TBL] [Abstract][Full Text] [Related]
11. Changing perceptions and practices regarding aspirin, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs among US primary care providers. Elnachef N; Scheiman JM; Fendrick AM; Howden CW; Chey WD Aliment Pharmacol Ther; 2008 Nov; 28(10):1249-58. PubMed ID: 18729848 [TBL] [Abstract][Full Text] [Related]
12. What happened to the prescribing of other COX-2 inhibitors, paracetamol and non-steroidal anti-inflammatory drugs when rofecoxib was withdrawn in Australia? Barozzi N; Tett SE Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1184-91. PubMed ID: 17636557 [TBL] [Abstract][Full Text] [Related]
13. Do rural consumers expect a prescription from their GP visit? Investigation of patients' expectations for a prescription and doctors' prescribing decisions in rural Australia. Cutts C; Tett SE Aust J Rural Health; 2005 Feb; 13(1):43-50. PubMed ID: 15720314 [TBL] [Abstract][Full Text] [Related]
14. A rural/urban comparison of the roles of the general practitioner in colorectal cancer management. Hanks H; Veitch PC; Harris MF Aust J Rural Health; 2008 Dec; 16(6):376-82. PubMed ID: 19032211 [TBL] [Abstract][Full Text] [Related]
15. Identification of barriers to the implementation of evidence-based practice for pre-hospital thrombolysis. Bloe C; Mair C; Call A; Fuller A; Menzies S; Leslie SJ Rural Remote Health; 2009; 9(1):1100. PubMed ID: 19278299 [TBL] [Abstract][Full Text] [Related]
17. Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study. Depont F; Fourrier A; Merlière Y; Droz C; Amouretti M; Bégaud B; Bénichou J; Moride Y; Velo GP; Sturkenboom M; Blin P; Moore N; Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):891-900. PubMed ID: 17351983 [TBL] [Abstract][Full Text] [Related]
18. How do rural GPs manage their inactive and overweight patients?--A pilot study of rural GPs in Queensland. Eley DS; Eley RM Aust Fam Physician; 2009 Sep; 38(9):747-8. PubMed ID: 19893808 [TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitors: perspectives of patients and their GPs. Grime J; Pollock K; Blenkinsopp A Br J Gen Pract; 2001 Sep; 51(470):703-11. PubMed ID: 11593830 [TBL] [Abstract][Full Text] [Related]
20. Utilization of non-steroidal anti-inflammatory drugs in Quebec: adherence to the Canadian consensus on prescription guidelines. Moride Y; Ducruet T; Boivin JF; Lavoie F; Rochon S Can J Clin Pharmacol; 2005; 12(2):e201-11. PubMed ID: 15998959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]